Bond.az White LogoBond.az Black Logo

#arcus-biosciences

Latest news and interesting information about arcus-biosciences.

Yesterday / 11:25
|
722

Truist Starts Arcus Biosciences at Buy on RCC Potential

Truist Securities initiates Arcus Biosciences with Buy rating and $35 price target, citing casdatifan's potential in renal cell carcinoma and immunology pipeline.

0
...